ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Glutamine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-12R16831
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Pharmaceutical Grade Glutamine Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical Grade Glutamine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-12R16831
Report
November 2025
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Kyowa Hakko Kirin
Daesang
Meihua
Fufeng

Pharmaceutical Grade Glutamine Market Size

The global Pharmaceutical Grade Glutamine market is projected to grow from US$ 69.6 million in 2024 to US$ 88.3 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Pharmaceutical Grade Glutamine Market

Pharmaceutical Grade Glutamine Market

Glutamine, short as Gln, is the most abundant amino acid in the body. It is responsible for transporting nitrogen into your muscles. Glutamine also plays a large role in metabolism, the functioning of your immune system, protein synthesis and energy restoration.
From a downstream perspective, Injection accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Grade Glutamine leading manufacturers including Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua, Fufeng, etc., dominate supply; the top five capture approximately % of global revenue, with Ajinomoto leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharmaceutical Grade Glutamine market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmaceutical Grade Glutamine Market Report

Report Metric Details
Report Name Pharmaceutical Grade Glutamine Market
Accounted market size in 2024 US$ 69.6 in million
Forecasted market size in 2031 US$ 88.3 million
CAGR 3.5%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Content ≤99%
  • Content ＞99%
Segment by Application
  • Injection
  • Granule
  • Tablet
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua, Fufeng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmaceutical Grade Glutamine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Pharmaceutical Grade Glutamine Market growing?

Ans: The Pharmaceutical Grade Glutamine Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Pharmaceutical Grade Glutamine Market size in 2031?

Ans: The Pharmaceutical Grade Glutamine Market size in 2031 will be US$ 88.3 million.

Who are the main players in the Pharmaceutical Grade Glutamine Market report?

Ans: The main players in the Pharmaceutical Grade Glutamine Market are Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua, Fufeng

What are the Application segmentation covered in the Pharmaceutical Grade Glutamine Market report?

Ans: The Applications covered in the Pharmaceutical Grade Glutamine Market report are Injection, Granule, Tablet, Others

What are the Type segmentation covered in the Pharmaceutical Grade Glutamine Market report?

Ans: The Types covered in the Pharmaceutical Grade Glutamine Market report are Content ≤99%, Content ＞99%

1 Study Coverage
1.1 Introduction to Pharmaceutical Grade Glutamine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Grade Glutamine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Content ≤99%
1.2.3 Content ＞99%
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Grade Glutamine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injection
1.3.3 Granule
1.3.4 Tablet
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Grade Glutamine Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Grade Glutamine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Grade Glutamine Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Grade Glutamine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Pharmaceutical Grade Glutamine Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Pharmaceutical Grade Glutamine Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Pharmaceutical Grade Glutamine Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Content ≤99% Market Size by Manufacturers
4.5.2 Content ＞99% Market Size by Manufacturers
4.6 Global Pharmaceutical Grade Glutamine Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Pharmaceutical Grade Glutamine Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Grade Glutamine Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Pharmaceutical Grade Glutamine Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Pharmaceutical Grade Glutamine Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Pharmaceutical Grade Glutamine Sales and Revenue by Type (2020-2031)
7.4 North America Pharmaceutical Grade Glutamine Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Pharmaceutical Grade Glutamine Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Pharmaceutical Grade Glutamine Sales and Revenue by Type (2020-2031)
8.4 Europe Pharmaceutical Grade Glutamine Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Pharmaceutical Grade Glutamine Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Pharmaceutical Grade Glutamine Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Pharmaceutical Grade Glutamine Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Pharmaceutical Grade Glutamine Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Pharmaceutical Grade Glutamine Sales and Revenue by Type (2020-2031)
10.4 Central and South America Pharmaceutical Grade Glutamine Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Pharmaceutical Grade Glutamine Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Pharmaceutical Grade Glutamine Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Pharmaceutical Grade Glutamine Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Pharmaceutical Grade Glutamine Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Ajinomoto
12.1.1 Ajinomoto Corporation Information
12.1.2 Ajinomoto Business Overview
12.1.3 Ajinomoto Pharmaceutical Grade Glutamine Product Models, Descriptions and Specifications
12.1.4 Ajinomoto Pharmaceutical Grade Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Ajinomoto Pharmaceutical Grade Glutamine Sales by Product in 2024
12.1.6 Ajinomoto Pharmaceutical Grade Glutamine Sales by Application in 2024
12.1.7 Ajinomoto Pharmaceutical Grade Glutamine Sales by Geographic Area in 2024
12.1.8 Ajinomoto Pharmaceutical Grade Glutamine SWOT Analysis
12.1.9 Ajinomoto Recent Developments
12.2 Kyowa Hakko Kirin
12.2.1 Kyowa Hakko Kirin Corporation Information
12.2.2 Kyowa Hakko Kirin Business Overview
12.2.3 Kyowa Hakko Kirin Pharmaceutical Grade Glutamine Product Models, Descriptions and Specifications
12.2.4 Kyowa Hakko Kirin Pharmaceutical Grade Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Kyowa Hakko Kirin Pharmaceutical Grade Glutamine Sales by Product in 2024
12.2.6 Kyowa Hakko Kirin Pharmaceutical Grade Glutamine Sales by Application in 2024
12.2.7 Kyowa Hakko Kirin Pharmaceutical Grade Glutamine Sales by Geographic Area in 2024
12.2.8 Kyowa Hakko Kirin Pharmaceutical Grade Glutamine SWOT Analysis
12.2.9 Kyowa Hakko Kirin Recent Developments
12.3 Daesang
12.3.1 Daesang Corporation Information
12.3.2 Daesang Business Overview
12.3.3 Daesang Pharmaceutical Grade Glutamine Product Models, Descriptions and Specifications
12.3.4 Daesang Pharmaceutical Grade Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Daesang Pharmaceutical Grade Glutamine Sales by Product in 2024
12.3.6 Daesang Pharmaceutical Grade Glutamine Sales by Application in 2024
12.3.7 Daesang Pharmaceutical Grade Glutamine Sales by Geographic Area in 2024
12.3.8 Daesang Pharmaceutical Grade Glutamine SWOT Analysis
12.3.9 Daesang Recent Developments
12.4 Meihua
12.4.1 Meihua Corporation Information
12.4.2 Meihua Business Overview
12.4.3 Meihua Pharmaceutical Grade Glutamine Product Models, Descriptions and Specifications
12.4.4 Meihua Pharmaceutical Grade Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Meihua Pharmaceutical Grade Glutamine Sales by Product in 2024
12.4.6 Meihua Pharmaceutical Grade Glutamine Sales by Application in 2024
12.4.7 Meihua Pharmaceutical Grade Glutamine Sales by Geographic Area in 2024
12.4.8 Meihua Pharmaceutical Grade Glutamine SWOT Analysis
12.4.9 Meihua Recent Developments
12.5 Fufeng
12.5.1 Fufeng Corporation Information
12.5.2 Fufeng Business Overview
12.5.3 Fufeng Pharmaceutical Grade Glutamine Product Models, Descriptions and Specifications
12.5.4 Fufeng Pharmaceutical Grade Glutamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Fufeng Pharmaceutical Grade Glutamine Sales by Product in 2024
12.5.6 Fufeng Pharmaceutical Grade Glutamine Sales by Application in 2024
12.5.7 Fufeng Pharmaceutical Grade Glutamine Sales by Geographic Area in 2024
12.5.8 Fufeng Pharmaceutical Grade Glutamine SWOT Analysis
12.5.9 Fufeng Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Pharmaceutical Grade Glutamine Industry Chain
13.2 Pharmaceutical Grade Glutamine Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Pharmaceutical Grade Glutamine Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Pharmaceutical Grade Glutamine Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Pharmaceutical Grade Glutamine Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Pharmaceutical Grade Glutamine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Kyowa Hakko Kirin
Daesang
Meihua
Fufeng
List of Tables
 Table 1. Global Pharmaceutical Grade Glutamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmaceutical Grade Glutamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmaceutical Grade Glutamine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmaceutical Grade Glutamine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pharmaceutical Grade Glutamine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Pharmaceutical Grade Glutamine Sales by Region (2020-2025) & (Tons)
 Table 8. Global Pharmaceutical Grade Glutamine Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pharmaceutical Grade Glutamine Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Pharmaceutical Grade Glutamine Production by Region (2020-2025) & (Tons)
 Table 12. Global Pharmaceutical Grade Glutamine Production by Region (2026-2031) & (Tons)
 Table 13. Global Pharmaceutical Grade Glutamine Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Pharmaceutical Grade Glutamine Sales Share by Manufacturers (2020-2025)
 Table 15. Global Pharmaceutical Grade Glutamine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Pharmaceutical Grade Glutamine Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Pharmaceutical Grade Glutamine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Glutamine as of 2024)
 Table 19. Global Pharmaceutical Grade Glutamine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Pharmaceutical Grade Glutamine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Pharmaceutical Grade Glutamine Manufacturing Base and Headquarters
 Table 22. Global Pharmaceutical Grade Glutamine Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Pharmaceutical Grade Glutamine Sales by Type (2020-2025) & (Tons)
 Table 26. Global Pharmaceutical Grade Glutamine Sales by Type (2026-2031) & (Tons)
 Table 27. Global Pharmaceutical Grade Glutamine Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical Grade Glutamine Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Pharmaceutical Grade Glutamine ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Pharmaceutical Grade Glutamine Sales by Application (2020-2025) & (Tons)
 Table 32. Global Pharmaceutical Grade Glutamine Sales by Application (2026-2031) & (Tons)
 Table 33. Pharmaceutical Grade Glutamine High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Pharmaceutical Grade Glutamine Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Pharmaceutical Grade Glutamine Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Pharmaceutical Grade Glutamine ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Pharmaceutical Grade Glutamine Growth Accelerators and Market Barriers
 Table 40. North America Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Pharmaceutical Grade Glutamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Pharmaceutical Grade Glutamine Growth Accelerators and Market Barriers
 Table 43. Europe Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Pharmaceutical Grade Glutamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Pharmaceutical Grade Glutamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Pharmaceutical Grade Glutamine Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Pharmaceutical Grade Glutamine Investment Opportunities and Key Challenges
 Table 50. Central and South America Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Pharmaceutical Grade Glutamine Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Pharmaceutical Grade Glutamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Ajinomoto Corporation Information
 Table 54. Ajinomoto Description and Major Businesses
 Table 55. Ajinomoto Product Models, Descriptions and Specifications
 Table 56. Ajinomoto Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Ajinomoto Sales Value Proportion by Product in 2024
 Table 58. Ajinomoto Sales Value Proportion by Application in 2024
 Table 59. Ajinomoto Sales Value Proportion by Geographic Area in 2024
 Table 60. Ajinomoto Pharmaceutical Grade Glutamine SWOT Analysis
 Table 61. Ajinomoto Recent Developments
 Table 62. Kyowa Hakko Kirin Corporation Information
 Table 63. Kyowa Hakko Kirin Description and Major Businesses
 Table 64. Kyowa Hakko Kirin Product Models, Descriptions and Specifications
 Table 65. Kyowa Hakko Kirin Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Kyowa Hakko Kirin Sales Value Proportion by Product in 2024
 Table 67. Kyowa Hakko Kirin Sales Value Proportion by Application in 2024
 Table 68. Kyowa Hakko Kirin Sales Value Proportion by Geographic Area in 2024
 Table 69. Kyowa Hakko Kirin Pharmaceutical Grade Glutamine SWOT Analysis
 Table 70. Kyowa Hakko Kirin Recent Developments
 Table 71. Daesang Corporation Information
 Table 72. Daesang Description and Major Businesses
 Table 73. Daesang Product Models, Descriptions and Specifications
 Table 74. Daesang Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Daesang Sales Value Proportion by Product in 2024
 Table 76. Daesang Sales Value Proportion by Application in 2024
 Table 77. Daesang Sales Value Proportion by Geographic Area in 2024
 Table 78. Daesang Pharmaceutical Grade Glutamine SWOT Analysis
 Table 79. Daesang Recent Developments
 Table 80. Meihua Corporation Information
 Table 81. Meihua Description and Major Businesses
 Table 82. Meihua Product Models, Descriptions and Specifications
 Table 83. Meihua Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Meihua Sales Value Proportion by Product in 2024
 Table 85. Meihua Sales Value Proportion by Application in 2024
 Table 86. Meihua Sales Value Proportion by Geographic Area in 2024
 Table 87. Meihua Pharmaceutical Grade Glutamine SWOT Analysis
 Table 88. Meihua Recent Developments
 Table 89. Fufeng Corporation Information
 Table 90. Fufeng Description and Major Businesses
 Table 91. Fufeng Product Models, Descriptions and Specifications
 Table 92. Fufeng Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Fufeng Sales Value Proportion by Product in 2024
 Table 94. Fufeng Sales Value Proportion by Application in 2024
 Table 95. Fufeng Sales Value Proportion by Geographic Area in 2024
 Table 96. Fufeng Pharmaceutical Grade Glutamine SWOT Analysis
 Table 97. Fufeng Recent Developments
 Table 98. Key Raw Materials Distribution
 Table 99. Raw Materials Key Suppliers
 Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 101. Milestones in Production Technology Evolution
 Table 102. Distributors List
 Table 103. Market Trends and Market Evolution
 Table 104. Market Drivers and Opportunities
 Table 105. Market Challenges, Risks, and Restraints
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceutical Grade Glutamine Product Picture
 Figure 2. Global Pharmaceutical Grade Glutamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Content ≤99% Product Picture
 Figure 4. Content ＞99% Product Picture
 Figure 5. Global Pharmaceutical Grade Glutamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Injection
 Figure 7. Granule
 Figure 8. Tablet
 Figure 9. Others
 Figure 10. Pharmaceutical Grade Glutamine Report Years Considered
 Figure 11. Global Pharmaceutical Grade Glutamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Pharmaceutical Grade Glutamine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Pharmaceutical Grade Glutamine Revenue Market Share by Region (2020-2031)
 Figure 15. Global Pharmaceutical Grade Glutamine Sales (2020-2031) & (Tons)
 Figure 16. Global Pharmaceutical Grade Glutamine Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global Pharmaceutical Grade Glutamine Sales Market Share by Region (2020-2031)
 Figure 18. Global Pharmaceutical Grade Glutamine Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global Pharmaceutical Grade Glutamine Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global Pharmaceutical Grade Glutamine Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Pharmaceutical Grade Glutamine Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. Pharmaceutical Grade Glutamine Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. Pharmaceutical Grade Glutamine Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. Pharmaceutical Grade Glutamine Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers Pharmaceutical Grade Glutamine Sales Volume Market Share in 2024
 Figure 27. Global Pharmaceutical Grade Glutamine Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. Content ≤99% Revenue Market Share by Manufacturer in 2024
 Figure 30. Content ＞99% Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global Pharmaceutical Grade Glutamine Sales Market Share by Type (2020-2031)
 Figure 34. Global Pharmaceutical Grade Glutamine Revenue Market Share by Type (2020-2031)
 Figure 35. Global Pharmaceutical Grade Glutamine Sales Market Share by Application (2020-2031)
 Figure 36. Global Pharmaceutical Grade Glutamine Revenue Market Share by Application (2020-2031)
 Figure 37. North America Pharmaceutical Grade Glutamine Sales YoY (2020-2031) & (Tons)
 Figure 38. North America Pharmaceutical Grade Glutamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) in 2024
 Figure 40. North America Pharmaceutical Grade Glutamine Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America Pharmaceutical Grade Glutamine Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe Pharmaceutical Grade Glutamine Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe Pharmaceutical Grade Glutamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) in 2024
 Figure 50. Europe Pharmaceutical Grade Glutamine Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe Pharmaceutical Grade Glutamine Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 55. France Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific Pharmaceutical Grade Glutamine Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific Pharmaceutical Grade Glutamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific Pharmaceutical Grade Glutamine Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific Pharmaceutical Grade Glutamine Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 70. India Pharmaceutical Grade Glutamine Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America Pharmaceutical Grade Glutamine Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America Pharmaceutical Grade Glutamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America Pharmaceutical Grade Glutamine Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America Pharmaceutical Grade Glutamine Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil Pharmaceutical Grade Glutamine Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina Pharmaceutical Grade Glutamine Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa Pharmaceutical Grade Glutamine Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa Pharmaceutical Grade Glutamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa Pharmaceutical Grade Glutamine Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa Pharmaceutical Grade Glutamine Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa Pharmaceutical Grade Glutamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries Pharmaceutical Grade Glutamine Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey Pharmaceutical Grade Glutamine Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt Pharmaceutical Grade Glutamine Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa Pharmaceutical Grade Glutamine Revenue (2020-2025) & (US$ Million)
 Figure 91. Pharmaceutical Grade Glutamine Industry Chain Mapping
 Figure 92. Regional Pharmaceutical Grade Glutamine Manufacturing Base Distribution (%)
 Figure 93. Pharmaceutical Grade Glutamine Production Process
 Figure 94. Regional Pharmaceutical Grade Glutamine Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Nutraceutical Grade Glutamine Market Research Report 2024
Global Glutamine Gln Market Research Report 2025
Global L Glutamine Gln Market Research Report 2025
Global Food Grade USP L Glutamine Market Research Report 2024
Global L Glutamine USP Market Research Report 2024
Global Pharma Grade L Glutamine Market Research Report 2025
Global Food Grade L Glutamine Market Research Report 2025
Global High Purity L glutamine Market Research Report 2025
Global Pharma Grade Glutamine Market Research Report 2024
Global D Glutamine Market Research Report 2024
Global Food Grade Glutamine Market Research Report 2024
Global Nutraceutical Grade L glutamine Market Research Report 2024
Global Glutamine Assay Kit Market Research Report 2025
Global Arginine for Feed Market Research Report 2024
Global L Arginine Supplement Market Research Report 2024
Global L Glutamic Acid Market Insights Forecast to 2030
Global Pharmaceutical Grade USP L Glutamine Market Research Report 2024
Global Pharma Grade Arginine Market Research Report 2024
Global Arginine Market Research Report 2025
Global L Glutamine Supplement Market Research Report 2024

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions